Trials / Unknown
UnknownNCT01411748
Comparison of Saccharomyces Boulardii and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Zekai Tahir Burak Women's Health Research and Education Hospital · Academic / Other
- Sex
- All
- Age
- 1 Day – 90 Days
- Healthy volunteers
- Not accepted
Summary
Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Saccharomyces boulardii was shown to reduce candida colonization. The objective of this study is to evaluate the efficacy of prophylactic S boulardii in reducing the candida colonization and infection in very low birth weight infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Reflor | 5 million unit/day, orally, beginning on the second day of life, until discharge from hospital |
| DRUG | mikostatin | 50000 unit/3 times a day, both for orally and by orogastric route |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-08-08
- Last updated
- 2011-08-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01411748. Inclusion in this directory is not an endorsement.